Tiziana Life Sciences Ltd
TLSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723069
In the last 90 days, Tiziana Life Sciences Ltd insiders filed 4 open-market purchases and 0 sales; 30 institutions reported holding it in 13F filings for Q2 2026, worth $3.10M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Tiziana Life Sciences Ltd changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 25 | 23 | −2 |
| Shares | 5.33M | 5.28M | −45.6K (−0.9%) |
| Value | $4.15M | $3.17M | −$980.2K (−23.6%) |
New holders (3)
Institutions that held Tiziana Life Sciences Ltd at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 39,193 | $23.7K | 0.00% |
| Money Concepts Capital Corp | 100 | $60 | 0.00% |
| Simplex Trading, LLC | 465 | $0 | 0.00% |
Sold out (5)
Institutions that held Tiziana Life Sciences Ltd at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Warberg Asset Management LLC | 22,000 | $17.0K |
| Virtu Financial LLC | 15,577 | $12.0K |
| Jane Street Group, LLC | 10,139 | $8.00K |
| BlackRock Inc. | 1,656 | $1.00K |
| US Bancorp | 500 | $0 |